heart failure

New AHA Statement on Complementary Medicine in Heart Failure

New AHA Statement on Complementary Medicine in Heart Failure

There are some potentially serious benefits and risks associated with complementary and alternative medicine (CAM) that patients with heart failure (HF) can use to manage symptoms, the American Heart Association (AHA) says in a new scientific statement on the subject. For example, yoga and tai chi may be helpful for people with heart failure, and …

New AHA Statement on Complementary Medicine in Heart Failure Read More »

Home air purifiers may improve markers of cardiovascular health in people with COPD

Home air purifiers may improve markers of cardiovascular health in people with COPD

A six-month study by researchers at Johns Hopkins Medicine finds that using portable home air purifiers can improve certain markers of cardiovascular health in people with chronic obstructive pulmonary disease, or COPD. People with COPD often suffer from shortness of breath, chest tightness and chronic cough. Cardiovascular diseases such as arrhythmias, heart failure, strokes and …

Home air purifiers may improve markers of cardiovascular health in people with COPD Read More »

The Intersection of Machine Learning and Medicine: New UW Medicine Study Reveals Key Predictors of Right Heart Failure Following LVAD Implantation

The Intersection of Machine Learning and Medicine: New UW Medicine Study Reveals Key Predictors of Right Heart Failure Following LVAD Implantation

If you’re a “Grey’s Anatomy” fan, chances are the word “LVAD wire” probably means something to you. Unlike the show, left ventricular assist devices (LVADs) possess capabilities far beyond the realm of hospital romance. An LVAD is a mechanical pump designed for patients with advanced heart failure. They are implanted in the apex of the …

The Intersection of Machine Learning and Medicine: New UW Medicine Study Reveals Key Predictors of Right Heart Failure Following LVAD Implantation Read More »

Optimal Implementation of Sodium-Glucose-2 Cotransporter Inhibitors in US Heart Failure Patients Estimated to Result in Significant Reduction in Worsening of Heart Failure Events Over 3 Years |  Medicine in 2 Minutes

Optimal Implementation of Sodium-Glucose-2 Cotransporter Inhibitors in US Heart Failure Patients Estimated to Result in Significant Reduction in Worsening of Heart Failure Events Over 3 Years | Medicine in 2 Minutes

1. In this analytical decision-making model study of 4.8 million adults with heart failure in the United States, the optimal implementation of sodium-glucose cotransporter-2 (SGLT-2) inhibitors over 3 years has been estimated to prevent or delay 630,000 events of worsening heart failure on the left ventricular ejection fraction (LVEF) spectrum, of which approximately 230,000 to …

Optimal Implementation of Sodium-Glucose-2 Cotransporter Inhibitors in US Heart Failure Patients Estimated to Result in Significant Reduction in Worsening of Heart Failure Events Over 3 Years | Medicine in 2 Minutes Read More »